Atlas market file · Equity · United States
Braskem SaBAK
- Last close
- 2.33
- Change
- +3.10%
- 96-bar range
- 2.2 – 5.395
- As of
- 6 Aug 2026
Braskem Sa is an industrial organic chemicals issuer listed as BAK on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-63.19% over the window).
Source rail: Yahoo Finance chart API (BAK). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for BAK. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BAK public profile
Industrial organic chemicals issuer. Braskem Sa is connected to current market context, cited company sources and its retained research file.
Braskem Sa trades as BAK on NYSE. Braskem Sa (BAK) has a latest verified close of 2.33, up 3.10%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BAK under USA Stocks for browsing.
What changed for Braskem Sa today
Braskem’s sustainability and technical-service pages read like a corporate brochure designed to impress ESG raters rather than a disclosure designed to inform investors. The company’s Product Stewardship and Technical Service & Development units promise ethical oversight of health, safety, and environmental risks across product life cycles, and they even point to Safety Data Sheets and Regulatory Information Sheets as evidence of transparency. What they don’t do is show how much revenue these functions generate, how many customers rely on them, or how the company validates those claims outside its own press releases and hero images.
The company’s main site and investor-relations portal reinforce a narrative of circular-economy commitment and carbon neutrality, but the evidence rails lack the hard numbers that would translate green slogans into cash flow. There are no disclosed capex figures for sustainability initiatives, no customer retention rates for technical services, and no filings that tie Braskem’s ESG pledges to measurable financial outcomes. The visuals are polished, the language is confident, and the disclosures are thin.
The Product Stewardship page explicitly states that Braskem commits to ensuring applicable chemical compliance and provides transparent product safety information via Regulatory Information Sheets and Safety Data Sheets, which can be found on the site. The Technical Service & Development page promotes ‘Ready Packaging’ as a solution, but offers no evidence of adoption, customer feedback, or revenue contribution. The investor-relations portal features Braskem’s logo and negative preference share branding, yet the site does not disclose how-if at all-the sustainability and technical services units contribute to revenue, profit, or cash flow. The evidence rails do not quantify the scale of these operations or their financial impact.
Braskem operates as a Brazilian petrochemical giant with a global footprint, but the public sources provided do not include filings or earnings data that would allow investors to assess the company’s financial performance or the materiality of its sustainability and technical-service activities. The company’s own product pages and investor-relations portal are rich in imagery and language but poor in audited metrics. The absence of revenue, profit, cash flow, capex, or customer data in the evidence means any claim about the financial significance of Product Stewardship or Technical Service & Development remains an act of faith rather than a statement of fact.
The product pages and investor-relations portal do not provide a chart route or market mechanism for assessing Braskem’s equity performance, so there is no TradingView-style price context to include here. The file’s sole purpose is to interrogate what the company claims against what its public disclosures actually prove. Without filings or earnings data, the file cannot ground its analysis in revenue, net income, EPS, cash flow, buybacks, dilution, or guidance. The reader is left with the company’s own promotional materials and unquantified assertions, which do not substitute for verified financials.
What changed today: nothing in the evidence rails. The company’s public pages, product stewardship section, and investor-relations portal remain unchanged from prior disclosures. There is no new filings, earnings, or governance update provided in the source rails. The file therefore stands as a static snapshot of a company whose real operating metrics and financial performance remain undisclosed in the materials supplied. The tension lies in the gap between the polished ESG story and the absence of audited financial evidence that would anchor that story to reality.
Sources & evidence · 5 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BAK technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BAK
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BAK research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BAK FAQ
What is Braskem Sa (BAK)?Braskem Sa (BAK) has a latest verified close of 2.33, up 3.10%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks...
Braskem Sa (BAK) has a latest verified close of 2.33, up 3.10%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BAK?Braskem Sa (BAK) has a latest verified close of 2.33, up 3.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...
Braskem Sa (BAK) has a latest verified close of 2.33, up 3.10%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BAK under USA Stocks for browsing.
How often is the BAK page updated?The BAK public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BAK public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BAK?The BAK file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:BAK. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The BAK file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:BAK. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BAK?Yes. The workstation can open BAK, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BAK, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BAK page investment advice?No. The BAK page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BAK page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
BAK
Equity · evidence first